A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer

A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer

Background. Breast cancer has an unacceptably high recurrence rate when any residual disease is found following neoadjuvant treatment of high-risk disease. Based on clinical data suggesting an adjuvant role for epigenetic modifying agents in breast cancer and preclinical data suggesting synergistic...

Full description

Bibliographic Details
Main Authors:	Trish Millard, Christiana Brenin, Clare Humphrey, Ajay Dhakal, Carla Falkson, Gina Petroni, Nolan A. Wages, Patrick Dillon
Format:	Article
Language:	English
Published:	Hindawi Limited 2024-01-01
Series:	International Journal of Breast Cancer
Online Access:	http://dx.doi.org/10.1155/2024/5515966

Similar Items

Efficient dose-finding for drug combination studies involving a shift in study populations
by: Nolan A. Wages, et al.
Published: (2020-03-01)

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer
by: Patrick M. Dillon, et al.
Published: (2017-11-01)

A web tool for designing and conducting phase I trials using the continual reassessment method
by: Nolan A. Wages, et al.
Published: (2018-02-01)

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
by: Narendra Bharathy, et al.
Published: (2019-05-01)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
by: Angelica Ferro, et al.
Published: (2023-02-01)

PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer
by: Ajay Dhakal, et al.
Published: (2021-11-01)

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer
by: Norikazu Masuda, et al.
Published: (2021-11-01)

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
by: Lars Ny, et al.
Published: (2021-08-01)

Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
by: Johanna K. Freundt, et al.
Published: (2019-03-01)

Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer
by: Maki Tanioka, et al.
Published: (2018-11-01)

Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data
by: Dillon PM, et al.
Published: (2020-04-01)

Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells.
by: Takumi Tomono, et al.
Published: (2018-01-01)

Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
by: Katherine H. Rak Tkaczuk
Published: (2011-01-01)

Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
by: Katherine H. Rak Tkaczuk
Published: (2011-01-01)

Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1
by: Chenyin Wang, et al.
Published: (2020-02-01)

MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells
by: Matteo Cassandri, et al.
Published: (2021-10-01)

Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
by: Simin Kiany, et al.
Published: (2017-08-01)

Response of Cutaneous Metastases from Breast Cancer to Capecitabine
by: Kostandinos Sideras, et al.
Published: (2008-01-01)

Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer
by: Michela Donadio
Published: (2018-06-01)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
by: Lanqi Ren, et al.
Published: (2023-08-01)

Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer
by: Claudio Vernieri, et al.
Published: (2020-03-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
by: E. A. Moskvina, et al.
Published: (2015-04-01)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
by: W. Si, et al.
Published: (2013-12-01)

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
by: Matthew N. Mills, et al.
Published: (2021-05-01)

Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer
by: Niraj Neupane, et al.
Published: (2024-01-01)

Capecitabine for the treatment of advanced gastric cancer
by: G Norman, et al.
Published: (2010-10-01)

Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape
by: Kristin C. Hicks, et al.
Published: (2021-08-01)

Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.
by: Li Shen, et al.
Published: (2012-01-01)

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.
by: Jingyuan Peng, et al.
Published: (2018-01-01)

Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study
by: Z. Einbeigi M.D., et al.
Published: (2008-01-01)

Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model
by: Yeeun Kim, et al.
Published: (2022-12-01)

Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.
by: Nadja Blagitko-Dorfs, et al.
Published: (2013-01-01)

Entinostat Improves Motor Function and Neuronal Damage Via Downregulating NLRP3 Inflammasome Activation After Spinal Cord Injury
by: Chen Dai, et al.
Published: (2021-11-01)

Capecitabine-Induced Coronary Vasospasm
by: Danish Henry, et al.
Published: (2016-10-01)

Capecitabine in the management of colorectal cancer
by: Hirsch BR, et al.
Published: (2011-03-01)

Capecitabine-induced terminal ileitis
by: Aboelkhair Mohammad Al-Gahmi, et al.
Published: (2012-11-01)

Exploring The Impact of Capecitabine Treatment on Hormonal and Biochemical Markers in Women with Breast Cancer
by: Raaid Fadhl Abbas Masoudi, et al.
Published: (2023-11-01)

Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case
by: E. V. Glazkova, et al.
Published: (2019-12-01)

Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
by: Xueqiong Xun, et al.
Published: (2022-07-01)

STUDY ON ADHERENCE TO CAPECITABINE AMONG PATIENTS WITH COLORECTAL CANCER AND METASTATIC BREAST CANCER
by: Adiel Goes de FIGUEIREDO JUNIOR, et al.
Published: (2014-09-01)